Jian-Feng Huang Selected Research

Stomatitis

1/2017

Induction chemotherapy followed by concurrent chemoradiation and nimotuzumab for locoregionally advanced nasopharyngeal carcinoma: preliminary results from a phase II clinical trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jian-Feng Huang Research Topics

Disease

7	Hypertension (High Blood Pressure) 08/2021 - 04/2008
3	Neoplasms (Cancer) 02/2021 - 05/2018
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022 - 07/2021
2	Renal Cell Carcinoma (Grawitz Tumor) 11/2021 - 02/2021
2	Endometrial Neoplasms (Endometrial Cancer) 02/2021 - 01/2015
2	Masked Hypertension 01/2021 - 10/2020
2	Inflammation (Inflammations) 01/2020 - 09/2019
2	Nasopharyngeal Carcinoma 01/2019 - 01/2017
2	Peripheral Vascular Diseases (Peripheral Vascular Disease) 01/2018 - 12/2017
2	Essential Hypertension 04/2008 - 06/2007
1	Hypothyroidism 02/2021
1	Squamous Cell Carcinoma of Head and Neck 02/2021
1	Diarrhea 02/2021
1	Stomach Neoplasms (Stomach Cancer) 02/2021
1	Proteinuria 02/2021
1	Fatigue 02/2021
1	Melanoma (Melanoma, Malignant) 02/2021
1	Aortic Dissection 01/2021
1	Breast Neoplasms (Breast Cancer) 01/2021
1	Autoimmune Diseases (Autoimmune Disease) 01/2020
1	Lung Injury 09/2019
1	Pulmonary Edema 09/2019
1	Drowning 09/2019
1	Acute Lung Injury 09/2019
1	Immune System Diseases (Immune Disorders) 06/2019
1	Disease Progression 01/2019
1	Body Weight (Weight, Body) 01/2019
1	Cholestasis 10/2018
1	Gastrointestinal Diseases (Functional Gastrointestinal Disorders) 01/2018
1	Dermatitis 01/2017
1	Neutropenia 01/2017
1	Stomatitis 01/2017
1	Allergic Rhinitis 10/2013
1	Atopic Dermatitis (Atopic Eczema) 10/2013
1	Asthma (Bronchial Asthma) 10/2013
1	Cardiovascular Diseases (Cardiovascular Disease) 06/2007

Drug/Important Bio-Agent (IBA)

3	Immune Checkpoint InhibitorsIBA 01/2022 - 07/2021
2	triptolideIBA 01/2020 - 06/2019
2	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 01/2018 - 12/2017
1	TeaIBA 08/2021
1	A 17 (A-17)IBA 08/2021
1	pembrolizumabIBA 02/2021
1	lenvatinibIBA 02/2021
1	SodiumIBA 01/2021
1	neratinibIBA 01/2021
1	Antihypertensive Agents (Antihypertensives)IBA 01/2021
1	LipidsIBA 01/2021
1	Dietary SodiumIBA 01/2021
1	Biomarkers (Surrogate Marker)IBA 01/2021
1	mahuang-tangIBA 10/2020
1	Pharmaceutical PreparationsIBA 01/2020
1	celastrolIBA 01/2020
1	Transaminases (Aminotransferases)IBA 01/2020
1	Keratins (Keratin)IBA 09/2019
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 09/2019
1	AntioxidantsIBA 09/2019
1	Heme Oxygenase-1IBA 09/2019
1	zinc protoporphyrinIBA 09/2019
1	Hemoglobins (Hemoglobin)IBA 01/2019
1	Prealbumin (Transthyretin)IBA 01/2019
1	thiamine triphosphorate (TTP)IBA 01/2019
1	Bile Acids and Salts (Bile Acids)IBA 10/2018
1	Arginine (L-Arginine)FDA Link 10/2018
1	ErbB Receptors (EGF Receptor)IBA 01/2017
1	nimotuzumabIBA 01/2017
1	Progesterone Receptors (Progesterone Receptor)IBA 01/2015
1	Estrogen ReceptorsIBA 01/2015
1	Adrenal Cortex Hormones (Corticosteroids)IBA 10/2013
1	Immunoglobulin E (IgE)IBA 10/2013
1	Cystathionine gamma-Lyase (Cysteine Desulfhydrase)IBA 04/2008
1	Hydrogen Sulfide (Sulfide, Hydrogen)IBA 04/2008
1	Apolipoproteins B (ApoB)IBA 06/2007
1	ApolipoproteinsIBA 06/2007

Therapy/Procedure

4	Therapeutics 11/2021 - 01/2021
1	Drug Therapy (Chemotherapy) 01/2022
1	Secondary Prevention 03/2021
1	Blood Pressure Monitors 08/2020
1	Radiotherapy 01/2019
1	Nephrectomy 05/2018
1	Sutures (Suture) 05/2018
1	Warm Ischemia 05/2018
1	Length of Stay 05/2018
1	Chinese Traditional Medicine (Traditional Chinese Medicine) 01/2018
1	Induction Chemotherapy 01/2017
1	Immunotherapy 10/2013